retinoblastoma (Cancer)

Search with Google Search with Bing
Information
Disease name
retinoblastoma
Disease ID
DOID:768
Description
"A retinal cell cancer and malignant neoplasm of retina and neuroblastoma and neuroendocrine tumors that derives_from the tissues of the retina." [url:http\://www.cancer.gov/cancertopics/types/retinoblastoma]
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
BRCA2 13 32,315,508 32,400,268 4
KIF1B 1 10,210,570 10,381,603 2
XPA 9 97,674,909 97,697,340 2
RECQL4 8 144,511,288 144,517,833 2
CDKN1B 12 12,717,368 12,722,212 2
CFTR 7 117,480,025 117,668,665 2
ABRAXAS1 4 83,459,517 83,485,100 2
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04156347 Active, not recruiting Phase 1 Topotecan Episcleral Plaque for Treatment of Retinoblastoma June 16, 2021 October 14, 2024
NCT04483778 Active, not recruiting Phase 1 B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults July 13, 2020 December 2040
NCT04342572 Active, not recruiting Phase 1 Intra-arterial Chemotherapy for Retinoblastoma August 11, 2020 January 4, 2025
NCT01906814 Active, not recruiting Phase 3 Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation August 2013 April 2024
NCT00110110 Active, not recruiting Phase 2 Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma June 2004 December 31, 2024
NCT00186888 Active, not recruiting Phase 3 Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma April 7, 2005 January 2025
NCT01783535 Active, not recruiting Phase 2 Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma June 19, 2013 January 2028
NCT02866136 Active, not recruiting Phase 2 Conservative Treatments of Retinoblastoma February 2012 September 2035
NCT00006102 Completed Phase 2 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma July 2000
NCT00006246 Completed Phase 1 Busulfan in Treating Children and Adolescents With Refractory CNS Cancer November 2000
NCT00024258 Completed Phase 2 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors March 2001 May 2009
NCT00053118 Completed Phase 1 Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer March 2002 July 2004
NCT00179920 Completed Phase 2 Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma April 1996 September 2006
NCT00336531 Completed Phase 4 Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation April 2006 October 2008
NCT00342797 Completed Retinoblastoma Biomarker Study November 17, 1993 March 6, 2024
NCT04429139 Completed N/A Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study February 1, 2011 May 30, 2020
NCT00445965 Completed Phase 2 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer January 2006 February 1, 2023
NCT00460876 Completed Phase 1 Phase I Trial of Periocular Topotecan in Retinoblastoma March 2007 April 2008
NCT00582049 Completed Research on the Environment and Children's Health: Retinoblastoma August 2003 June 2008
NCT04164134 Completed New Strategies to Detect Cancers in Carriers of Mutations in RB1 December 13, 2018 March 31, 2023
NCT00718783 Completed Molecular Analysis of Retinoblastoma April 2007 December 2016
NCT00857519 Completed N/A A Study of the Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma January 2009 April 2014
NCT00901238 Completed Phase 1/Phase 2 Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma May 2006 July 2009
NCT03935074 Completed Superselective Intra-arterial Chemotherapy Treatment for Retinoblastoma- 5 Year Results From Turkey August 30, 2016 November 30, 2016
NCT03764930 Completed Attention to Retinoblastoma Diagnosed in the Trauma Setting January 1, 2013 November 30, 2018
NCT01048892 Completed Phase 1 Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features September 2009
NCT03677128 Completed N/A Mobile Health Case Management System for Reducing Pediatric Treatment Abandonment July 23, 2019 April 22, 2022
NCT01331135 Completed Phase 1 Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors April 2011 August 9, 2017
NCT02792036 Completed Phase 1 Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma November 1, 2016 October 4, 2019
NCT02764398 Completed Cardio-respiratory Events During Ophthalmic Artery Chemotherapy for Retinoblastoma Under a Deep Anesthesia December 2013
NCT01505569 Completed N/A Auto Transplant for High Risk or Relapsed Solid or CNS Tumors October 20, 2011 February 1, 2024
NCT02390843 Completed Phase 1 Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors February 2015 September 22, 2019
NCT01598454 Completed Phase 1 Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides February 2011 June 2015
NCT02319486 Completed Phase 4 CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma January 2009 April 2014
NCT01661400 Completed Phase 1 Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors October 26, 2012 December 27, 2023
NCT01884194 Completed Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging November 2013 February 2015
NCT00002675 Completed Phase 2 Chemotherapy in Treating Patients With Retinoblastoma May 1995 January 2001
NCT00002794 Completed Phase 2 Carboplatin Plus Vincristine in Treating Children With Retinoblastoma February 1996 June 2001
NCT00003022 Completed Phase 1 Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer April 1997 January 2005
NCT00003173 Completed Phase 2 High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors September 1997 May 2003
NCT00002515 Completed Phase 2 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer October 1992 April 2005
NCT06367569 Completed Evaluation of MRI of the Pineal Gland in Retinoblastoma October 1, 2012 September 1, 2023
NCT00004006 Completed Phase 2 Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma November 1997 September 2005
NCT02193724 Completed Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma November 4, 2014 August 23, 2019
NCT06227962 Enrolling by invitation Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors October 26, 2023 March 31, 2028
NCT03655223 Enrolling by invitation Early Check: Expanded Screening in Newborns October 15, 2018 December 31, 2025
NCT06424301 Not yet recruiting Early Phase 1 Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma May 21, 2024 May 21, 2027
NCT04425434 Recruiting Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma November 1, 2020 October 2029
NCT04428879 Recruiting Phase 1 Topotecan Episcleral Plaque for Treatment of Retinoblastoma June 16, 2020 October 15, 2030
NCT02870907 Recruiting Phase 2 Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) March 2010 September 2030
NCT03016156 Recruiting N/A Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma March 15, 2018 July 30, 2026
NCT03050268 Recruiting Familial Investigations of Childhood Cancer Predisposition April 6, 2017 March 31, 2037
NCT03267459 Recruiting Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma? January 11, 2018 July 2026
NCT03546387 Recruiting Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients May 7, 2018 May 7, 2025
NCT03618381 Recruiting Phase 1 EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults June 18, 2019 June 2040
NCT06367530 Recruiting Trilateral Retinoblastoma: Incidence and Outcomes January 1, 2024 December 31, 2029
NCT01109394 Recruiting Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies April 21, 2010
NCT05080010 Recruiting Phase 3 Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma November 1, 2020 December 31, 2030
NCT03932786 Recruiting Studying Health Outcomes After Treatment in Patients With Retinoblastoma January 24, 2019 January 2031
NCT00898755 Recruiting Collecting and Storing Tissue From Young Patients With Cancer March 5, 2007
NCT00639301 Recruiting Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life March 2008 March 2025
NCT04564521 Recruiting N/A Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma. September 28, 2020 December 30, 2024
NCT04681417 Recruiting Phase 2/Phase 3 Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome March 25, 2021 January 20, 2036
NCT04700514 Recruiting N/A Effect of Anesthetic Drugs on Neurocognitive Function in Children With Retinoblastoma Requiring Multiple Anesthetic Exposure - Preliminary Study February 5, 2021 February 20, 2025
NCT04799002 Recruiting Phase 3 Topotecan and Melphalan for Retinoblastoma March 11, 2021 December 30, 2027
NCT04959097 Recruiting RB Liquid Biopsy Biorepository January 1, 2017 December 31, 2030
NCT00432445 Terminated Phase 2 Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma January 2007 February 2014
NCT02617862 Terminated N/A PCI Imaging System in Pediatric Ophthalmology October 2015 September 2017
NCT00003926 Terminated Phase 1 Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors November 1998 August 2003
NCT01987596 Terminated Phase 3 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer August 2013 June 2018
NCT01642823 Terminated Cancer Biology of Retinoblastoma July 2012 December 2015
NCT00623077 Terminated Phase 1 MT2004-30: Tomotherapy for Solid Tumors August 2005 October 2016
NCT01558960 Terminated N/A Intravitreal Injections of Melphalan for Retinoblastoma March 2012 August 2015
NCT01857752 Terminated Phase 2 Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala March 2012 June 2015
NCT01466855 Terminated Early Phase 1 A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma October 2011 October 2015
NCT01393769 Terminated Phase 2 Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage November 2009 May 2013
NCT01293539 Terminated Phase 2 Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma March 2011 August 2016
NCT02116959 Terminated Phase 1 Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma July 23, 2014 May 25, 2019
NCT05028270 Unknown status Treatment of Intraocular Retinoblastoma June 20, 2022 August 1, 2023
NCT02137928 Unknown status Phase 3 Carboplatin Periocular Injection for Retinoblastoma January 2006 December 2015
NCT02329002 Unknown status SPT Screening in Irradiated Hereditary Retinoblastoma Survivors October 2014 October 2023
NCT02933333 Unknown status Phase 4 G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor September 27, 2016 December 2020
NCT03439397 Unknown status N/A RCT of Ballon Technique VS Selective Ophthalmic Artery Infusion For the Retinoblastoma Patients March 2018 December 2020
NCT03559894 Unknown status Severe and Transient Hypoxemia During Selective Intra-arterial Chemotherapy for Retinoblastoma in Children: Evaluation of the Right-sided Heart Function. January 1, 2018 May 31, 2019
NCT00906113 Unknown status Phase 1/Phase 2 Intra-arterial Chemotherapy for Children With Retinoblastoma June 2011 December 2017
NCT04344652 Unknown status N/A Photoscreening for Retinoblastoma June 1, 2020 May 31, 2021
NCT04451304 Unknown status Autonomic Reflexes During Intra-arterial Chemotherapy for Retinoblastoma June 15, 2020 July 15, 2021
NCT00360750 Unknown status N/A Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye September 2005
NCT04990271 Unknown status Phase 2 A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma July 5, 2021 July 15, 2023
NCT01899066 Unknown status Phase 2 Efficacy Study of Lucentis in the Treatment of Retinoblastoma July 2013 December 2015
NCT05308043 Unknown status Deep Learning in Retinoblastoma Detection and Monitoring. March 1, 2020 October 1, 2022
NCT00278031 Unknown status Quality of Life in Children Cured of Retinoblastoma March 2006 December 2017
NCT00003273 Withdrawn Phase 2 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor November 1997
NCT01151748 Withdrawn Phase 2 Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma September 2010 March 2012
NCT00980551 Withdrawn N/A Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma May 2010 March 2012
NCT02655432 Withdrawn Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population January 2016 June 2016
Disase is a (Disease Ontology)
DOID:771
Cross Reference ID (Disease Ontology)
GARD:7563
Cross Reference ID (Disease Ontology)
ICDO:9510/3
Cross Reference ID (Disease Ontology)
MESH:D012175
Cross Reference ID (Disease Ontology)
MIM:180200
Cross Reference ID (Disease Ontology)
NCI:C7541
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:154553002
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0035335
Exact Synonym (Disease Ontology)
neuroblastoma of Retina
Exact Synonym (Disease Ontology)
RB
Exact Synonym (Disease Ontology)
RB - Retinoblastoma
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0009919
OrphaNumber from OrphaNet (Orphanet)
790
MeSH unique ID (MeSH (Medical Subject Headings))
D012175